2019 annual financial data

Trevi Therapeutics 2019 Operating margin

Trevi Therapeutics 2019 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -26,645,000 USD and net income was -26,050,000 USD.
Operating cash flow was -23,093,000 USD.

Get free Trevi Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-26,645,000 USD
Net income
-26,050,000 USD
Operating cash flow
-23,093,000 USD